Panacea Life Sciences, Inc Closes Series A Investment Round with 22nd Century Group to Expand CBD Operations
Investment bolsters expansion of Panacea’s CBD manufacturing capabilities and leverages 22nd Century's strengths in packaged-goods and FDA-regulatory affairs. GOLDEN, COLORADO, UNITED STATES, January 15, 2020 /EINPresswire.com/ -- Panacea Life …